As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the second half of 2024 in the “Cancer Immunology and Immunotherapy” Section, which are listed below:

1. “Dendritic Cells in Shaping Anti-Tumor T Cell Response”
by Luciano Mazzoccoli and Bei Liu
Cancers 2024, 16(12), 2211; https://doi.org/10.3390/cancers16122211
Available online: https://www.mdpi.com/2072-6694/16/12/2211

2. “Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma”
by Paola Tacchetti, Simona Barbato, Katia Mancuso, Elena Zamagni and Michele Cavo
Cancers 2024, 16(13), 2337; https://doi.org/10.3390/cancers16132337
Available online: https://www.mdpi.com/2072-6694/16/13/2337

3. “Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors and CAR-T Cell Therapy: A Comprehensive Imaging-Based Review”
by Chiara Pozzessere, Bianca Mazini, Patrick Omoumi, Mario Jreige, Leslie Noirez, Antonia Digklia, François Fasquelle, Christine Sempoux and Clarisse Dromain
Cancers 2024, 16(14), 2585; https://doi.org/10.3390/cancers16142585
Available online: https://www.mdpi.com/2072-6694/16/14/2585

4. “Strategies for Improving CAR T Cell Persistence in Solid Tumors”
by Megen C. Wittling, Anna C. Cole, Brianna Brammer, Kailey G. Diatikar, Nicole C. Schmitt and Chrystal M. Paulos
Cancers 2024, 16(16), 2858; https://doi.org/10.3390/cancers16162858
Available online: https://www.mdpi.com/2072-6694/16/16/2858

5. “Contemporary Approaches to Immunotherapy of Solid Tumors”
by Alla V. Kuznetsova, Xenia A. Glukhova, Olga P. Popova, Igor P. Beletsky and Alexey A. Ivanov
Cancers 2024, 16(12), 2270; https://doi.org/10.3390/cancers16122270
Available online: https://www.mdpi.com/2072-6694/16/12/2270

6. “Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future Directions”
by Tulika Ranjan, Vivek Podder, Kim Margolin, Vamsidhar Velcheti, Arun Maharaj and Manmeet Singh Ahluwalia
Cancers 2024, 16(19), 3388; https://doi.org/10.3390/cancers16193388
Available online: https://www.mdpi.com/2072-6694/16/19/3388

7. “Beyond Anti-PD-1/PD-L1: Improving Immune Checkpoint Inhibitor Responses in Triple-Negative Breast Cancer”
by Kennady K. Bullock and Ann Richmond
Cancers 2024, 16(12), 2189; https://doi.org/10.3390/cancers16122189
Available online: https://www.mdpi.com/2072-6694/16/12/2189

8. “Present and Future of Immunotherapy for Triple-Negative Breast Cancer”
by Sushmitha Sriramulu, Shivani Thoidingjam, Corey Speers and Shyam Nyati
Cancers 2024, 16(19), 3250; https://doi.org/10.3390/cancers16193250
Available online: https://www.mdpi.com/2072-6694/16/19/3250

9. “Site-Specific Response and Resistance Patterns in Patients with Advanced Non-Small-Cell Lung Cancer Treated with First-Line Systemic Therapy”
by Lauren Julia Brown, Julie Ahn, Bo Gao, Harriet Gee, Adnan Nagrial, Eric Hau and Inês Pires da Silva
Cancers 2024, 16(11), 2136; https://doi.org/10.3390/cancers16112136
Available online: https://www.mdpi.com/2072-6694/16/11/2136

10. “Topical and Intralesional Immunotherapy for the Management of Basal Cell Carcinoma”
by Aurora Fernández-Galván, Pedro Rodríguez-Jiménez, Beatriz González-Sixto, María Teresa Abalde-Pintos and Beatriz Butrón-Bris
Cancers 2024, 16(11), 2135; https://doi.org/10.3390/cancers16112135
Available online: https://www.mdpi.com/2072-6694/16/11/2135

11. “Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints”
by Huijie Liu, Ayse Ece Cali Daylan, Jihua Yang, Ankit Tanwar, Alain Borczuk, Dongwei Zhang, Vincent Chau, Shenduo Li, Xuan Ge, Balazs Halmos et al.
Cancers 2024, 16(16), 2805; https://doi.org/10.3390/cancers16162805
Available online: https://www.mdpi.com/2072-6694/16/16/2805

12. “Advancement and Challenges in Monitoring of CAR-T Cell Therapy: A Comprehensive Review of Parameters and Markers in Hematological Malignancies”
by Weronika Ploch, Karol Sadowski, Wioletta Olejarz and Grzegorz W. Basak
Cancers 2024, 16(19), 3339; https://doi.org/10.3390/cancers16193339
Available online: https://www.mdpi.com/2072-6694/16/19/3339

13. “Current Knowledge and Perspectives of Immunotherapies for Neuroblastoma”
by Chenkai Mao, Maria Poimenidou and Brian T. Craig
Cancers 2024, 16(16), 2865; https://doi.org/10.3390/cancers16162865
Available online: https://www.mdpi.com/2072-6694/16/16/2865

14. “IFNγ-Induced Bcl3, PD-L1 and IL-8 Signaling in Ovarian Cancer: Mechanisms and Clinical Significance”
by Suprataptha U. Reddy, Fatema Zohra Sadia, Ales Vancura and Ivana Vancurova
Cancers 2024, 16(15), 2676; https://doi.org/10.3390/cancers16152676
Available online: https://www.mdpi.com/2072-6694/16/15/2676

15. “Cutaneous Squamous Cell Carcinoma of the Head and Neck: Pathological Features and What They Mean for Prognosis and Treatment”
by Uma Ramesh, Elizabeth Chiang, Haleigh Stafford, Jane Buell, Frank Materia, Moran Amit and Dan Yaniv
Cancers 2024, 16(16), 2866; https://doi.org/10.3390/cancers16162866
Available online: https://www.mdpi.com/2072-6694/16/16/2866

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office